Search Results - "Lerman, O. V"

Long-term prognosis of life in patients with cerebrovascular accident: the role of diabetes mellitus (according to the REGION-M registry outpatient follow-up phase) by Voronina, V. P., Zagrebelny, A. V., Lukina, Yu. V., Tolpygina, S. N., Kutishenko, N. P., Chernysheva, M. I., Lukyanov, M. M., Dmitrieva, N. A., Lerman, O. V., Martsevich, S. Yu, Drapkina, O. M.

“…Aim . To study the long-term prognosis of patients’ life who have suffered cerebrovascular accident (CVA), and to determine the role of diabetes mellitus (DM)…”
Get full text

Ursodeoxycholic acid-enhanced efficiency and safety of statin therapy in patients with liver, gallbladder, and/or biliary tract diseases: the RACURS study by Martsevish, S Iu, Kutishenko, N P, Drozdova, L Iu, Lerman, O V, Nevzorova, V A, Reznik, I I, Shavkuta, G V, Iakhontov, D A, RACURS study group

“…To evaluate the efficiency and safety of using statins in combination with ursodeoxycholic acid (UDCA) in patients with this or another liver disease at high…”
Get full text

The problem of obesity «through the eyes» of patients (results of the survey of patients of the outpatient registry) by Lerman, O. V., Lukina, Yu. V., Kutishenko, N. P., Martsevich, S. Yu, Drapkina, O. M.

“…Aim. To assess, based on the results of the questionnaire, patients' awareness of the presence, possible causes and health effects of overweight /obesity; to…”
Get full text

Long-term survival of patients with cerebrovascular accident, depending on sex and age: data from the REGION-M registry by Tolpygina, S. N., Zagrebelny, A. V., Chernysheva, M. I., Kutishenko, N. P., Voronina, V. P., Dmitrieva, N. A., Lerman, O. V., Lukina, Yu. V., Lukyanov, M. M., Okshina, E. Yu, Parsadanyan, N. E., Martsevich, S. Yu, Drapkina, O. M.

“…Aim. To study the long-term survival of patients with cerebrovascular accident, depending on sex and age. Material and methods. The outpatient part of the…”
Get full text

Medical follow-up and long-term survival of patients with cerebrovascular accident: data from the REGION-M registry by Tolpygina, S. N., Chernysheva, M. I., Zagrebelny, A. V., Voronina, V. P., Kutishenko, N. P., Dmitrieva, N. A., Lerman, O. V., Lukina, Yu. V., Lukyanov, M. M., Okshina, E. Yu, Parsadanyan, N. E., Martsevich, S. Yu, Drapkina, O. M.

“…Aim. To assess the survival rate of patients after cerebrovascular accident (CVA), depending on the visits to the local outpatient clinic and the type of…”
Get full text

Two-year outcomes in patients after hospitalization for COVID-19: data from the TARGET-VIP registry by Lukyanov, M. M., Andreenko, E. Yu, Martsevich, S. Yu, Kutishenko, N. P., Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Kudryavtseva, M. M., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Pulin, A. A., Smirnov, А. А., Klyashtorny, V. G., Karpov, O. E., Drapkina, O. M.

“…Aim . To evaluate 24-month outcomes after hospital treatment of patients with coronavirus disease 2019 (COVID-19) in a prospective registry. Material and…”
Get full text

Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) by Martsevich, S. Yu, Lukina, Yu. V., Kutishenko, N. P., Zagrebelnyy, A. V., Tolpygina, S. N., Voronina, V. P., Dmitrieva, N. A., Lerman, O. V., Nekoshnova, E. S., Budaeva, I. V., Blagodatskikh, S. V., Aslanova, B. B.

“…Aim . To identify the main problems of statin therapy in patients with high and very high cardiovascular (CV) risk in real clinical practice. Material and…”
Get full text

Long-term survival of patients after cerebrovascular accident with prior coronary artery disease: data from the outpatient stage of REGION-M registry by Tolpygina, S. N., Zagrebelny, A. V., Chernysheva, M. I., Voronina, V. P., Kutishenko, N. P., Dmitrieva, N. A., Lerman, O. V., Lukina, Yu. V., Blagodatskikh, S. V., Lukyanov, M. M., Okshina, E. Yu, Parsadanyan, N. E., Martsevich, S. Yu, Parsadanyan, N. E.

“…Aim . To study two-year survival and factors affecting it in patients with cerebrovascular accident (CVA) with prior coronary artery disease (CAD). Material…”
Get full text

Long-term survival of patients with cerebrovascular accident in different age groups in the REGION-M registry by Tolpygina, S. N., Zagrebelny, A. V., Chernysheva, M. I., Voronina, V. P., Kutishenko, N. P., Dmitrieva, N. A., Lerman, O. V., Lukina, Yu. V., Blagodatskikh, S. V., Lukyanov, M. M., Okshina, E. Yu, Parsadanyan, N. E., Martsevich, S. Yu, Drapkina, O. M.

“…Aim. To study the two-year survival rate of patients with cerebrovascular accident (CVA) in different age groups. Material and methods . The outpatient part of…”
Get full text

Long-term survival of patients with various types of cerebrovascular accident: data from the outpatient part of the REGION-M registry by Tolpygina, S. N., Zagrebelny, A. V., Chernysheva, M. I., Voronina, V. P., Kutishenko, N. P., Dmitrieva, N. A., Lerman, O. V., Lukina, Yu. V., Blagodatskikh, S. V., Lukyanov, M. M., Okshina, E. Yu, Parsadanyan, N. E., Martsevich, S. Yu, Drapkina, O. M.

“…Aim. To study the two-year survival rate of patients with various types of cerebrovascular accident according to the outpatient part of the REGION-M registry…”
Get full text

Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization by Mareev, Yu. V., Lukyanov, M. M., Martsevich, S. Yu, Pulin, A. A., Kutishenko, N. P., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Makoveeva, A. N., Lerman, O. V., Okshina, E. Yu, Smirnov, A. A., Kudryavtseva, M. M., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. To estimate the detection rate of heart failure (HF), using various diagnosis criteria, among patients aftr 12 months after hospital treatment for…”
Get full text

Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19 by Kutishenko, N. P., Lukyanov, M. M., Martsevich, S. Yu, Pulin, A. A., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Kudryavtseva, M. M., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Smirnov, А. А., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. To evaluate the medical treatment of patients with cardiovascular disease (CVD) during the first year of follow-up after hospitalization for coronavirus…”
Get full text

Main factors of adherence to new oral anticoagulants and its dynamics in outpatients with nonvalvular atrial fibrillation: results of the ANTEY study by Lukina, Yu. V., Kutishenko, N. P., Tolpygina, S. N., Voronina, V. P., Dmitrieva, N. A., Lerman, O. V., Komkova, N. A., Zagrebelny, A. V., Martsevich, S. Yu, Drapkina, O. M.

“…Aim. To assess adherence to new oral anticoagulants (NOAC) or warfarin therapy and to study the factors influencing adherence in nonvalvular atrial…”
Get full text

Detection and Treatment of Hyperuricemia in Clinical Practice (According to the PROFILE Outpatient Registry) by Kutishenko, N. P., Martsevich, S. Yu, Zagrebelnyy, A. V., Lukina, Yu. V., Voronina, V. P., Dmitrieva, N. A., Lerman, O. V., Tolpygina, S. N., Blagodatskikh, S. V., Budaeva, I. V., Nekoshnova, E. S., Drapkina, O. M.

“…Aim . To study the frequency of detection of hyperuricemia (HU) in patients with high and very high cardiovascular risk and the frequency of prescribing drugs…”
Get full text

Medical treatment of obesity: peculiarities of medical treatments, information, responsibility and relation to medical treatment of obesity of patients by Lerman, O. V., Lukina, Yy. V., Kutishenko, N. P., Martsevich, S. Yu

“…The aim to evaluate medical appointments, as well as awareness, adherence and attitude of patients to medical treatment of obesity based on the results of a…”
Get full text

Long-term outcomes in patients after COVID-19: data from the TARGET-VIP registry by Lukyanov, M. M., Kutishenko, N. P., Martsevich, S. Yu, Pulin, A. A., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Sgibneva, A. S., Smirnov, A. A., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim . To assess long-term outcomes within 12 months after hospital treatment of patients with coronavirus disease 2019 (COVID-19) as part of a prospective…”
Get full text

Adherence to Attendance at Outpatient Clinic and Longterm Survival of Patients after Stroke in Outpatient Setting: the Data of REGION-M Registry by Martsevich, S. Yu, Tolpygina, S. N., Chernysheva, M. I., Zagrebelny, A. V., Voronina, V. P., Lukyanov, M. M., Kutishenko, N. P., Dmitrieva, N. A., Lerman, O. V., Lukina, Yu. V., Blagodatskikh, S. V., Okshina, E. Yu, Parsadanyan, N. E.

“…Aim. Assess the two-year survival rate of patients who have undergone acute cerebral circulation disorder, depending on their commitment to visiting the…”
Get full text

Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data) by Martsevich, S. Yu, Lukyanov, M. M., Pulin, M. M., Kutishenko, N. P., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Zagrebelnyy, A. V., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Smirnov, A. A., Kudryashov, E. V., Budaeva, I. V., Nikoshnova, E. S., Karpov, O. E., Drapkina, O. M.

“…Aim . Based on the data from the register of patients with COVID-19 and community-acquired pneumonia (CAP), analyze the duration of the prehospital period,…”
Get full text

Dynamics of age characteristics and prevalence of concomitant cardiovascular and non-sardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave: data from TARGET-VIP registry by Lukyanov, M. M., Martsevich, S. Yu, Pulin, A. A., Kutishenko, N. P., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Zagrebelny, A. V., Makoveeva, A. N., Lerman, O. V., Okshina, E. Yu, Sgibneva, А. S., Smirnov, A. A., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. According to hospital-based registry, to evaluate the age characteristics and prevalence of concomitant cardiovascular and non-сardiovascular diseases in…”
Get full text

Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 by Smirnov, A. A., Loukianov, M. M., Martsevich, S. Yu, Pulin, A. A., Kutishenko, N. P., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Kudryavtseva, M. M., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Maltseva, A. A., Belova, E. N., Klyashtorniy, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. To study the clinical and anamnestic characteristics, pharmacotherapy of cardiovascular diseases (CVD) and long-term outcomes in post-COVID-19 patients…”
Get full text